Pericardoscopy for primary management of pericardial effusion in cancer patients

Objective: To assess the usefulness of pericardoscopy via the subxyphoid route for the diagnosis and treatment of pericardial effusion in patients with a history of cancer. Methods: All patients with a recent or remote history of cancer and a pericardial effusion of unknown origin requiring drainage...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of cardio-thoracic surgery Vol. 16; no. 3; pp. 287 - 291
Main Authors Porte, Henri L., Janecki-Delebecq, Thérèse J., Finzi, Laetitia, Métois, David G., Millaire, Alain, Wurtz, Alain J.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Science B.V 01.09.1999
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: To assess the usefulness of pericardoscopy via the subxyphoid route for the diagnosis and treatment of pericardial effusion in patients with a history of cancer. Methods: All patients with a recent or remote history of cancer and a pericardial effusion of unknown origin requiring drainage for diagnostic and therapeutic purposes were included in the study. They underwent complete exploration and cleansing of the pericardial cavity. Abnormal structures or deposits were biopsied under direct visual control, with a 24 cm long rigid pericardoscope. Results: Between 1985 and 1998, pericardoscopy was completed in 112 of the 114 patients included (feasibility 98 %), resulting in the immediate relief of symptoms in all the cases. Peri-operative mortality was 3.5%, and post-operative morbidity, 6.1%. After pericardioscopy pericardial effusions were considered malignant in 43 cases. One more case (2.3%) due to a false negative result of perycardioscopy was diagnosed during follow-up. Overall, 44 of the 114 patients (38.6%) had a malignant effusion, and 70 (61.4%), a non-malignant effusion according the follow up. In 10 of the 44 patients with a malignant pericardial effusion (22.7%), pericardoscopy corrected the results of cytological pericardial fluid studies and pericardial window biopsy, both false negatives. The sensitivities of cytological studies of the pericardial fluid, pathological examinations of pericardial window biopsy and pericardioscopy were 75, 65 and 97%, respectively. One patient with a malignant effusion had a non-symptomatic recurrence 1 month after pericardioscopy (2.3%). Conclusion: We recommend pericardioscopy to ascertain the malignant nature of the effusion and to diminish the recurrence rate, this avoiding repeat procedures in patients with a short life expectancy.
Bibliography:Corresponding author. Clinique Chirurgicale, Hôpital Calmette, Bd du Pr J. Leclercq, 59037 Lille Cedex, France. Tel.:+33-320-44-4559; fax: +33-320-44-4890
ark:/67375/HXZ-97VD6TD6-T
istex:49B3151228F2EDFEDE52B6C6629DBB81F8B8F034
PII:S1010794099002043
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1010-7940
1873-734X
DOI:10.1016/S1010-7940(99)00204-3